Patent foramen ovale closure in non-elderly and elderly patients with cryptogenic stroke: a hospital-based cohort

Po-Lin Chen1,2,3, Chi-Sheng Wang1, Jin-An Huang1,3,4

  • 1Division of Neurology, Taichung Veterans General Hospital, Neurological Institute, Taichung, Taiwan.

PubMed

Insights

Patent foramen ovale (PFO) closure reduced recurrent stroke and mortality in patients with cryptogenic stroke. Elderly patients undergoing PFO closure showed improved functional outcomes, suggesting its consideration in select older individuals.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Patent foramen ovale (PFO) is a common cardiac anomaly.
  • The efficacy of PFO closure in elderly patients with cryptogenic stroke (CS) remains unclear.

Purpose of the Study:

  • To investigate the efficacy and safety of PFO closure in non-elderly and elderly patients with CS.
  • To compare outcomes between PFO closure and medical management alone.

Main Methods:

  • Prospective enrollment of patients (≥18 years) with CS/TIA and PFO.
  • Classification into PFO closure (PFOC) and medical treatment (non-PFOC) groups.
  • Primary outcome: composite of recurrent cerebral ischemic events and all-cause mortality; secondary outcome: modified Ranking Scale (mRS) at 180 days.

Main Results:

  • PFO closure significantly reduced the primary outcome in the total cohort (6.2% vs. 17.1%, HR=0.35, p=0.043).
  • Elderly patients with PFO closure showed a numerically lower risk of the primary outcome (HR=0.26, p=0.051) and better functional outcomes (lower median mRS, p=0.002).
  • Safety outcomes were similar between groups and age categories.

Conclusions:

  • PFO closure is associated with reduced risk of recurrent events in patients with PFO and CS.
  • Elderly patients with PFO closure experience better functional outcomes.
  • PFO closure may be a viable option for selected elderly patients with PFO.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
11
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
26
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.3K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
19